23 May 2013
Keywords: respigam, effective, rsv, says, study, medimmune, respiratory
Article | 29 November 1993
Medimmune's respiratory syncytial virus treatment RespiGam can reduce the incidence of severe RSV infections by 72% in patients at risk of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.